Southern Acids (M) Bhd (XKLS:5134) Operating Income: RM76.7 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:5134 Southern Acids (M) Bhd XKLS:5134
69 GF Score
Price RM3.07
GF Value RM2.88
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Southern Acids (M) Bhd Operating Income?

Southern Acids (M) Bhd XKLS:5134 -0.97% 69 Operating Income is RM76.7 Mil as of Mar. 2026. GuruFocus rates XKLS:5134 with a GF Score™ of 69/100 and a GF Value™ of RM2.88 (Fairly Valued). The stock has 4 warning signs investors should review.

Southern Acids (M) Bhd's Operating Income for the three months ended in Mar. 2026 was RM34.7 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was RM76.7 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Southern Acids (M) Bhd's Operating Income for the three months ended in Mar. 2026 was RM34.7 Mil. Southern Acids (M) Bhd's Revenue for the three months ended in Mar. 2026 was RM201.8 Mil. Therefore, Southern Acids (M) Bhd's Operating Margin % for the quarter that ended in Mar. 2026 was 17.21%.

Warning Sign:

Southern Acids (M) Bhd operating margin has been in a 5-year decline. The average rate of decline per year is -6.5%.

Southern Acids (M) Bhd's 5-Year average Growth Rate for Operating Margin % was -6.50% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Southern Acids (M) Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was 20.90%. Southern Acids (M) Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 57.69%.


Southern Acids (M) Bhd  (XKLS:5134) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Southern Acids (M) Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=138.94 * ( 1 - 21.61% )/( (528.736 + 513.355)/ 2 )
=108.915066/521.0455
=20.90 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=992.305 - 62.065 - ( 401.504 - max(0, 93.115 - 596.243+401.504))
=528.736

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1025.179 - 73.219 - ( 438.605 - max(0, 95.565 - 620.164+438.605))
=513.355

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Southern Acids (M) Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=138.94/( ( (196.815 + max(44.347, 0)) + (204.595 + max(35.913, 0)) )/ 2 )
=138.94/( ( 241.162 + 240.508 )/ 2 )
=138.94/240.835
=57.69 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(31.721 + 82.113 + 7.122) - (62.065 + 0 + 14.544)
=44.347

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(39.224 + 75.386 + 5.546) - (73.219 + 0 + 11.024)
=35.913

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Southern Acids (M) Bhd's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=34.735/201.821
=17.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Southern Acids (M) Bhd Operating Income Related Terms


Southern Acids (M) Bhd Operating Income Historical Data

* Premium members only.

The historical data trend for Southern Acids (M) Bhd's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Southern Acids (M) Bhd Operating Income Chart

Southern Acids (M) Bhd Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 150.61 68.84 32.27 73.69 76.72

Southern Acids (M) Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.28 8.63 18.25 15.10 34.74
XKLS:5134
69GF Score
Southern Acids (M) Bhd XKLS:5134
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Southern Acids (M) Bhd Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM76.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of RM76.7 Mil mean?
Southern Acids (M) Bhd (XKLS:5134) has a Operating Income of RM76.7 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Southern Acids (M) Bhd and its competitors.
Is Southern Acids (M) Bhd's Operating Income too high?
Southern Acids (M) Bhd's current Operating Income is RM76.7 Mil. Overall, Southern Acids (M) Bhd has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's Operating Income compare to MMM and HON?
Southern Acids (M) Bhd's Operating Income of RM76.7 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Conglomerates company?
A good Operating Income depends on the Conglomerates industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Southern Acids (M) Bhd and its competitors. Southern Acids (M) Bhd's current Operating Income is RM76.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.88, compared to a current price of RM3.07 — trading 6.6% above its estimated fair value. The current Operating Income is RM76.7 Mil. Southern Acids (M) Bhd's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current Operating Income is RM76.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?

Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued. The current stock price of RM3.07 is trading 6.6% above its estimated GF Value™ of RM2.88. GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.

Key valuation signals for XKLS:5134:

  • Operating Income: RM76.7 Mil
  • GF Value™: RM2.88 vs. price of RM3.07 (6.6% above fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Southern Acids (M) Bhd Business Description

Address No. 8, Jalan Batu Tiga Lama, Level 29, Centro Tower, Klang, SGR, MYS, 41300
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
69GF Score

Get the complete analysis for XKLS:5134

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.07
Price
RM2.88
GF Value